Skip to main content
  • Final Push: Urge Your Senators to Support Access to Avastin


    There’s still time to encourage your senators to sign a letter to the U.S. Food and Drug Administration, urging the agency to abandon the one-size-fits-all approach to beyond-use dates outlined in its draft guidance.